114 related articles for article (PubMed ID: 34565620)
21. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
[TBL] [Abstract][Full Text] [Related]
22. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
23. Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Lett. 385 (2017) 65-74].
Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
Cancer Lett; 2022 Aug; 540():215739. PubMed ID: 35599097
[No Abstract] [Full Text] [Related]
24. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
[TBL] [Abstract][Full Text] [Related]
25. Cellular-based therapies to prevent or reduce thrombocytopenia.
Pineault N; Boyer L
Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
[TBL] [Abstract][Full Text] [Related]
26. Corrigendum to "Glioblastoma extracellular vesicles induce the tumour-promoting transformation of neural stem cells" [Canc. Lett. 466 (2019) 1-12].
Wang J; Liu J; Sun G; Meng H; Wang J; Guan Y; Yin Y; Zhao Z; Dong X; Yin S; Li H; Cheng Y; Wu H; Wu A; Yu X; Chen L
Cancer Lett; 2021 Feb; 498():245-246. PubMed ID: 33342533
[No Abstract] [Full Text] [Related]
27. Corrigendum to "Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-related manner" [Canc. Lett. 371 (2016) 354-365].
Zheng S; Chen H; Wang Y; Gao W; Fu Z; Zhou Q; Jiang Y; Lin Q; Tan L; Ye H; Zhao X; Luo Y; Li G; Ye L; Liu Y; Li W; Li Z; Chen R
Cancer Lett; 2022 Oct; 545():215859. PubMed ID: 35940956
[No Abstract] [Full Text] [Related]
28. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells.
Shultz LD; Banuelos SJ; Leif J; Appel MC; Cunningham M; Ballen K; Burzenski L; Greiner DL
Exp Hematol; 2003 Jun; 31(6):551-8. PubMed ID: 12829032
[TBL] [Abstract][Full Text] [Related]
29. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
[TBL] [Abstract][Full Text] [Related]
30. Immunodeficient NOD-scid IL-2Rγ(null) mice do not display T and B cell leakiness.
Katano I; Ito R; Eto T; Aiso S; Ito M
Exp Anim; 2011; 60(2):181-6. PubMed ID: 21512274
[TBL] [Abstract][Full Text] [Related]
31. An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.
Minamiguchi H; Wingard JR; Laver JH; Mainali ES; Shultz LD; Ogawa M
Biol Blood Marrow Transplant; 2005 Jul; 11(7):487-94. PubMed ID: 15983548
[TBL] [Abstract][Full Text] [Related]
32. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
Christianson SW; Greiner DL; Hesselton RA; Leif JH; Wagar EJ; Schweitzer IB; Rajan TV; Gott B; Roopenian DC; Shultz LD
J Immunol; 1997 Apr; 158(8):3578-86. PubMed ID: 9103418
[TBL] [Abstract][Full Text] [Related]
33. Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
Cancer Lett; 2022 Jul; 539():215700. PubMed ID: 35525812
[No Abstract] [Full Text] [Related]
34. A mouse model for ulcerative colitis based on NOD-scid IL2R γnull mice reconstituted with peripheral blood mononuclear cells from affected individuals.
Palamides P; Jodeleit H; Föhlinger M; Beigel F; Herbach N; Mueller T; Wolf E; Siebeck M; Gropp R
Dis Model Mech; 2016 Sep; 9(9):985-97. PubMed ID: 27491073
[TBL] [Abstract][Full Text] [Related]
35. Corrigendum to "Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway" [Canc. Lett. (2009) 282(2) 167-76 doi:10.1016/j.canlet.2009.03.003].
Bhui K; Prasad S; George J; Shukla Y
Cancer Lett; 2020 Jun; 480():48. PubMed ID: 32035655
[No Abstract] [Full Text] [Related]
36. Comparison of human cord blood engraftment between immunocompromised mouse strains.
McDermott SP; Eppert K; Lechman ER; Doedens M; Dick JE
Blood; 2010 Jul; 116(2):193-200. PubMed ID: 20404133
[TBL] [Abstract][Full Text] [Related]
37. Corrigendum to "Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway" [Canc. Lett. (2023) 216142].
Zhang Y; Chen J; Mi D; Ling J; Li H; He P; Liu N; Chen Q; Chen Y; Huang L
Cancer Lett; 2023 Jul; 567():216195. PubMed ID: 37156646
[No Abstract] [Full Text] [Related]
38. Nonobese diabetic/severe combined immunodeficient murine xenograft model for human uterine leiomyoma.
Wang G; Ishikawa H; Sone K; Kobayashi T; Kim JJ; Kurita T; Shozu M
Fertil Steril; 2014 May; 101(5):1485-92. PubMed ID: 24636398
[TBL] [Abstract][Full Text] [Related]
39. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells.
McKenzie JL; Gan OI; Doedens M; Dick JE
Blood; 2005 Aug; 106(4):1259-61. PubMed ID: 15878972
[TBL] [Abstract][Full Text] [Related]
40. Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
Cancer Lett; 2020 Mar; 473():200-201. PubMed ID: 31932121
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
